Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease
• The PARTNERS clinical trial has officially opened patient enrolment in the Democratic Republic of the Congo to identify the first effective treatments for Bundibugyo virus (BVD). • This international effort focuses on evaluating potential therapies for Ebola disease specifically caused by the BVD strain, utilizing facilities like the ALIMA Ebola Treatment Centre. • The trial is critical because it addresses a specific gap in medical countermeasures for a dangerous virus that causes severe hemorrhagic fever.
who.int











